Abeona Therapeutics Inc (ABEO.OQ)
ABEO.OQ on NASDAQ Stock Exchange Capital Market
4.43USD
24 Jun 2019
4.43USD
24 Jun 2019
Change (% chg)
$-0.19 (-4.11%)
$-0.19 (-4.11%)
Prev Close
$4.62
$4.62
Open
$4.73
$4.73
Day's High
$4.73
$4.73
Day's Low
$4.41
$4.41
Volume
240,940
240,940
Avg. Vol
133,652
133,652
52-wk High
$17.25
$17.25
52-wk Low
$4.41
$4.41
About
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)
Overall
| Beta: | 2.29 |
| Market Cap(Mil.): | $713.08 |
| Shares Outstanding(Mil.): | 40.29 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ABEO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.29 | 32.55 |
| EPS (TTM): | -0.60 | -- | -- |
| ROI: | -29.33 | 8.90 | 13.82 |
| ROE: | -30.75 | 10.04 | 15.24 |
Estimates